[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622834":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":19,"responsibleParty":46,"collaborators":10,"id":50,"slug":10,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":10,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"NSCLC with neoadjuvant therapy but without surgery",null,{"label":12,"type":10,"description":10,"interventionNames":10},"NSCLC with neoadjuvant therapy and surgery",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Minghao Hu","CONTACT","8613396366466","huminghao2010@126.com",[20,35],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Tongji hospital","RECRUITING","Wuhan","Hubei","430030","China",{"type":28,"coordinates":29},"Point",[30,31],114.26667,30.58333,{"lat":31,"lon":30},[34],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":10},{"facility":36,"status":22,"city":37,"state":38,"zip":25,"country":26,"cosmosGeoPoint":39,"geoPoint":43,"contacts":44},"Sir Run Run Shaw Hospital","Hangzhou","Zhejiang",{"type":28,"coordinates":40},[41,42],120.16142,30.29365,{"lat":42,"lon":41},[45],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},{"type":47,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Qian Chu","Director of the Thoracic Oncology Department","100622834",false,"NCT07388771","Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）","A Study on Multimodal Data Prediction of Outcome to Neoadjuvant Therapy in NSCLC","Inclusion Criteria:\n\n1. pathologically diagnosed non-small cell lung cancer\n2. The treatment plan is：receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection\n\nExclusion Criteria:\n\n1. recurrent or metastatic lung cancer;\n2. patients with other primary tumors","ALL","18 Years",{"count":59,"type":60},500,"ESTIMATED","6 Months","OBSERVATIONAL","This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC.\n\nThe core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?",[65,66],"NSCLC","Neoadjuvant Therapy","2026-03-18",{"date":69,"type":70},"2026-03-19","ACTUAL",{"date":72,"type":70},"2025-12-01",{"date":74,"type":60},"2026-10",{"name":48,"class":6},2]